These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 20042793)
1. Platelet-derived growth factors for GMP-compliant propagation of mesenchymal stromal cells. Schallmoser K; Rohde E; Bartmann C; Obenauf AC; Reinisch A; Strunk D Biomed Mater Eng; 2009; 19(4-5):271-6. PubMed ID: 20042793 [TBL] [Abstract][Full Text] [Related]
2. Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. Bieback K; Hecker A; Kocaömer A; Lannert H; Schallmoser K; Strunk D; Klüter H Stem Cells; 2009 Sep; 27(9):2331-41. PubMed ID: 19544413 [TBL] [Abstract][Full Text] [Related]
3. Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Schallmoser K; Bartmann C; Rohde E; Reinisch A; Kashofer K; Stadelmeyer E; Drexler C; Lanzer G; Linkesch W; Strunk D Transfusion; 2007 Aug; 47(8):1436-46. PubMed ID: 17655588 [TBL] [Abstract][Full Text] [Related]
4. Comparison of different culture conditions for human mesenchymal stromal cells for clinical stem cell therapy. Haack-Sorensen M; Friis T; Bindslev L; Mortensen S; Johnsen HE; Kastrup J Scand J Clin Lab Invest; 2008; 68(3):192-203. PubMed ID: 17852829 [TBL] [Abstract][Full Text] [Related]
5. Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine. Lange C; Cakiroglu F; Spiess AN; Cappallo-Obermann H; Dierlamm J; Zander AR J Cell Physiol; 2007 Oct; 213(1):18-26. PubMed ID: 17458897 [TBL] [Abstract][Full Text] [Related]
6. Two steps to functional mesenchymal stromal cells for clinical application. Bartmann C; Rohde E; Schallmoser K; Pürstner P; Lanzer G; Linkesch W; Strunk D Transfusion; 2007 Aug; 47(8):1426-35. PubMed ID: 17655587 [TBL] [Abstract][Full Text] [Related]
7. Matrix-mediated retention of adipogenic differentiation potential by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion. Mauney JR; Volloch V; Kaplan DL Biomaterials; 2005 Nov; 26(31):6167-75. PubMed ID: 15913765 [TBL] [Abstract][Full Text] [Related]
8. Selection of CD271(+) cells and human AB serum allows a large expansion of mesenchymal stromal cells from human bone marrow. Poloni A; Maurizi G; Rosini V; Mondini E; Mancini S; Discepoli G; Biasio S; Battaglini G; Felicetti S; Berardinelli E; Serrani F; Leoni P Cytotherapy; 2009; 11(2):153-62. PubMed ID: 19301169 [TBL] [Abstract][Full Text] [Related]
9. Comparison of ex vivo expansion culture conditions of mesenchymal stem cells for human cell therapy. Pérez-Ilzarbe M; Díez-Campelo M; Aranda P; Tabera S; Lopez T; del Cañizo C; Merino J; Moreno C; Andreu EJ; Prósper F; Pérez-Simón JA Transfusion; 2009 Sep; 49(9):1901-10. PubMed ID: 19497059 [TBL] [Abstract][Full Text] [Related]
10. Clinical grade production of mesenchymal stem cells. Sensebé L Biomed Mater Eng; 2008; 18(1 Suppl):S3-10. PubMed ID: 18334718 [TBL] [Abstract][Full Text] [Related]
11. Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: further insights in the search for a fetal calf serum substitute. Bernardo ME; Avanzini MA; Perotti C; Cometa AM; Moretta A; Lenta E; Del Fante C; Novara F; de Silvestri A; Amendola G; Zuffardi O; Maccario R; Locatelli F J Cell Physiol; 2007 Apr; 211(1):121-30. PubMed ID: 17187344 [TBL] [Abstract][Full Text] [Related]
12. Chondrogenic differentiation of bovine bone marrow mesenchymal stem cells (MSCs) in different hydrogels: influence of collagen type II extracellular matrix on MSC chondrogenesis. Bosnakovski D; Mizuno M; Kim G; Takagi S; Okumura M; Fujinaga T Biotechnol Bioeng; 2006 Apr; 93(6):1152-63. PubMed ID: 16470881 [TBL] [Abstract][Full Text] [Related]
13. Matrix-mediated retention of in vitro osteogenic differentiation potential and in vivo bone-forming capacity by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion. Mauney JR; Kirker-Head C; Abrahamson L; Gronowicz G; Volloch V; Kaplan DL J Biomed Mater Res A; 2006 Dec; 79(3):464-75. PubMed ID: 16752403 [TBL] [Abstract][Full Text] [Related]
15. Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM. Müller I; Kordowich S; Holzwarth C; Spano C; Isensee G; Staiber A; Viebahn S; Gieseke F; Langer H; Gawaz MP; Horwitz EM; Conte P; Handgretinger R; Dominici M Cytotherapy; 2006; 8(5):437-44. PubMed ID: 17050248 [TBL] [Abstract][Full Text] [Related]
16. Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Kocaoemer A; Kern S; Klüter H; Bieback K Stem Cells; 2007 May; 25(5):1270-8. PubMed ID: 17255520 [TBL] [Abstract][Full Text] [Related]
17. Bone-forming capacity of mesenchymal stromal cells when cultured in the presence of human platelet lysate as substitute for fetal bovine serum. Prins HJ; Rozemuller H; Vonk-Griffioen S; Verweij VG; Dhert WJ; Slaper-Cortenbach IC; Martens AC Tissue Eng Part A; 2009 Dec; 15(12):3741-51. PubMed ID: 19519274 [TBL] [Abstract][Full Text] [Related]
18. Increased proliferation of human synovial mesenchymal stem cells with autologous human serum: comparisons with bone marrow mesenchymal stem cells and with fetal bovine serum. Nimura A; Muneta T; Koga H; Mochizuki T; Suzuki K; Makino H; Umezawa A; Sekiya I Arthritis Rheum; 2008 Feb; 58(2):501-10. PubMed ID: 18240254 [TBL] [Abstract][Full Text] [Related]